10x Genomics (TXG) Net Cash Flow Growth (3y) (2021 - 2026)
10x Genomics (TXG) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.86 Bn | 19.54 Bn | 662.02 Mn | 31.95% |
| 2 | BrightSpring Health Services | 12.40 Bn | 11.52 Bn | 482.22 Mn | 590.29% |
| 3 | Healthequity | 7.57 Bn | 7.31 Bn | 256.31 Mn | -23.22% |
| 4 | Hinge Health | 4.86 Bn | 4.55 Bn | 154.23 Mn | - |
| 5 | Doximity | 3.78 Bn | 3.03 Bn | 125.97 Mn | 92.69% |
| 6 | 10x Genomics | 3.73 Bn | 3.19 Bn | 106.18 Mn | -47.37% |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.84 Bn | 2.47 Bn | 595.71 Mn | -17.84% |
| 9 | Omnicell | 1.73 Bn | 1.56 Bn | 140.36 Mn | 139.35% |
| 10 | Teladoc Health | 1.27 Bn | 518.34 Mn | 562.57 Mn | -0.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.37% |
| Dec 31, 2025 | 69.30% |
| Sep 30, 2025 | 42.15% |
| Jun 30, 2025 | 36.30% |
| Mar 31, 2025 | 28.45% |
| Dec 31, 2024 | -60.95% |
| Sep 30, 2024 | 34.94% |
| Jun 30, 2024 | 71.77% |
| Mar 31, 2024 | 57.46% |
| Dec 31, 2023 | 32.14% |
| Sep 30, 2023 | -26.77% |
| Jun 30, 2023 | 31.94% |
| Mar 31, 2023 | 65.43% |
| Dec 31, 2022 | -144.54% |
| Sep 30, 2022 | -27.98% |
| Jun 30, 2022 | -56.64% |
| Mar 31, 2022 | -582.37% |
| Dec 31, 2021 | 10.40% |